HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: possible common central Asian ancestral origin.

Abstract
Previous studies showed that almost all Ashkenazi Jewish patients with pemphigus vulgaris carried the extended haplotype [HLA-B38, SC21, DRB1*0402, DQB1*0302] or [HLA-B35, SC31, DRB1*0402, DQB1*0302] or class II fragments of them. Non-Jewish patients carried [HLA-B55, SB45, DRB1*1401, DQB1*0503] or its class II fragments. In the present study of 20 Iranian patients with pemphigus vulgaris, 17 were found to carry DRB1*0402, DQB1*0302 haplotypes, also found among normal Iranian haplotypes and the same as that of the Jews. These findings suggest that the pemphigus MHC susceptibility gene among Iranians derived from the same ancestor as that in the Ashkenazim. The ancient Jews were under Persian domination from 500 B.C. until 300 B.C. and in the 8th century A.D., a Tataric people living in the kingdom of Khazar on the Western shore of the Caspian Sea and the Northern shore of the Black Sea, near Persia, converted to Judaism, providing possible opportunities for gene mixing in two populations that are distinct and separate today.
AuthorsN Mobini, E J Yunis, C A Alper, J J Yunis, J C Delgado, D E Yunis, A Firooz, Y Dowlati, K Bahar, P K Gregersen, A R Ahmed
JournalHuman immunology (Hum Immunol) Vol. 57 Issue 1 Pg. 62-7 (Sep 15 1997) ISSN: 0198-8859 [Print] United States
PMID9438197 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Genetic Markers
  • HLA-DQ Antigens
  • HLA-DR Antigens
Topics
  • Asia
  • Genes, MHC Class II
  • Genetic Markers
  • HLA-DQ Antigens (genetics)
  • HLA-DR Antigens (genetics)
  • Haplotypes
  • Humans
  • Iran
  • Jews (genetics)
  • Major Histocompatibility Complex (genetics)
  • Pemphigus (genetics, immunology)
  • Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: